Puzzle Medical Devices is a Canadian medical technology startup that is changing the game in heart failure treatment. The company specializes in the development of a minimally invasive long-term hemodynamic transcatheter pump called ModulHeart, which is designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure who are not candidates for heart transplant or surgical mechanical circulatory support. Puzzle Medical’s groundbreaking technology is expected to provide sustained symptom relief, reduced re-hospitalizations and improved overall quality of life for patients with heart failure.
First-In-Human Study Success
Puzzle Medical Devices completed its first-in-human study in 2022 with all patients experiencing improvements in cardiac and kidney function. This success represents a significant milestone for the company and proves the potential effectiveness of ModulHeart in treating heart failure patients.
Innovative Technology
ModulHeart is a modular percutaneous heart pump that is anchored in parallel in the descending aorta. The device’s modular design allows for hemodynamic support through multiple pumps, which makes it more accessible than traditional heart pumps. The minimally invasive nature of the device’s implantation process reduces the risk of bleeding, stroke, and pump thrombosis while providing sustained symptom relief and improved quality of life for heart failure patients.
FDA Breakthrough Device Designation
Puzzle Medical Devices has received the U.S. Food and Drug Administration (FDA) Breakthrough Device Designation in 2021, which is a significant achievement for the company. This designation recognizes the potential of ModulHeart to provide more effective treatment for heart failure patients and fast tracks the device’s regulatory review process.
Key Opinion Leaders Committee
Puzzle Medical Devices has built a strong Key Opinion Leaders committee that includes some of the world’s leading experts in heart failure treatment. The committee’s role is to provide guidance and advice on the development and commercialization of ModulHeart. This team of experts provides a unique perspective on the device’s potential applications and ensures that Puzzle Medical Devices is moving in the right direction.
Conclusion
Puzzle Medical Devices is a Canadian startup that is transforming the way heart failure is treated. The company’s ModulHeart is a minimally invasive long-term hemodynamic transcatheter pump that is designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure. The device’s modular design allows for multiple pumps to be anchored in parallel in the descending aorta, making it more accessible and safer than traditional heart pumps. Puzzle Medical’s innovative technology has already shown success in its first-in-human study, and the FDA Breakthrough Device Designation highlights the potential of ModulHeart to revolutionize heart failure treatment.
Website: https://puzzlemed.com
LinkedIn: https://www.linkedin.com/company/puzzlemedicaldevices/
Looking to amplify your brand’s impact in Canada’s thriving startup and investment sector? Join the league of innovators, leaders, and decision-makers making a difference through Canada Venture News. Engage with our audience of startup founders, investors, and executives through sponsored articles and partnerships. Discover more on our Promotion & Sponsored Articles page or email us directly at [email protected]. Let’s shape your story together.
